Jabra Enhance Select 50R vs Lexie B3

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Select 50R demonstrates notable strengths in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.75 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical wear. Music streaming also performs above average at 2.8/5, though this remains mixed in absolute terms. The device shows limitations in challenging listening situations. Speech in noise scores just 1.0/5, falling 0.48 points below the category average—a meaningful weakness for those who frequently encounter noisy environments. Own-voice comfort is mixed at 2.5/5, essentially matching the category average. At this price point, shoppers should note that several competitors deliver stronger overall performance. The Jabra Enhance Select 500 scores 4.16/5, while the Lucid Tala and Audicus Omni 2 both exceed 4.5/5. For those prioritizing value, devices like the Sony CRE-C20 offer similar sound performance at lower prices. The Select 50R is best suited for users who primarily need help hearing in quieter settings and value Jabra's ecosystem and reliable feedback control.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.